Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
ACS Central Science|August 3, 2021
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.Journal of Medical Virology|September 19, 2022
Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapyRuthMabel Boytz, Mikołaj Słabicki, Sita Ramaswamy, et al.Cancer Research|July 5, 2014
Hsp70-Bag3 interactions regulate cancer-related signaling networksTeresa A Colvin, Vladimir L Gabai, Jianlin Gong, et al.Science Translational Medicine|November 12, 2025
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccineWataru Akahata, Mai Komori, Amber L Morey, et al.Frontiers in Immunology|April 26, 2021
Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 <i>via</i> Multi-Parameter DetectionRachel R Yuen, Dylan Steiner, Riley M F Pihl, et al.Biorxiv : the Preprint Server for Biology|April 28, 2021
Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivoJ J Patten, Patrick T Keiser, Deisy Gysi, et al.Iscience|August 22, 2022
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationJ J Patten, Patrick T Keiser, Deisy Morselli-Gysi, et al.Molecular Psychiatry|June 15, 2024
The single-cell opioid responses in the context of HIV (SCORCH) consortiumSeth A Ament, Rianne R Campbell, Mary Kay Lobo, et al.Pageof 7